However, for the vast majority of patients, access to brand-name semaglutide (sold as Wegovy for weight loss and Ozempic for type 2 diabetes by Novo Nordisk) is blocked by a single, massive hurdle: cost
Every single prescription written for this combination is off-label
The novel dual incretin analogue tirzepatide was shown to have superior effects compared to GLP-1R agonists in terms of weight loss, and tirzepatide was the first incretin analogue to show improved cardiovascular outcomes in a heart failure trial, however, so far only in patients with HFpEF [32]
For 0.25mg dose you need 0.15mL, which is great accuracy for micro-dosing
What the new study found One of the reasons the new study is so exciting is its sheer size: The researchers analyzed data on more than 110,000 women ages 45 to 80
The weekly dosing schedule remains consistent whether you inject Monday morning before eating or Thursday evening after dinner